id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2022-0145-0006,DEA,DEA-2022-0145,"Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I",Proposed Rule,,2025-07-25T04:00:00Z,2025,7,2025-07-25T04:00:00Z,2025-08-26T03:59:59Z,2025-08-21T09:01:13Z,2025-14022,0,0,09000064b8e9caad
DEA-2022-0145-0001,DEA,DEA-2022-0145,"Schedule of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I",Proposed Rule,,2022-12-23T05:00:00Z,2022,12,2022-12-23T05:00:00Z,,2022-12-23T12:54:22Z,2022-27278,0,0,0900006485550cf4